Compounds > lomerizine

lomerizine and quinoxalines

lomerizine has been researched along with quinoxalines in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hara, H; Harada, K; Sukamoto, T1
Bartlett, CA; Chiha, W; Fitzgerald, M; Giacci, MK; Harvey, AR; Hodgetts, SI; O'Hare Doig, RL; Smith, NM; Yates, NJ1
Fehily, B; Fitzgerald, M; Gavriel, N; Giacci, MK; Gough, AH; Gray, CGG; Milbourn, HR; Toomey, LM1
Bartlett, CA; Fitzgerald, M; Gopalasingam, G; Majimbi, M; Rodger, J; Toomey, LM1
Bartlett, CA; Fitzgerald, M; Gavriel, N; Gopalasingam, G; Majimbi, M; McGonigle, T; Rodger, J; Toomey, LM1

Reviews

1 review(s) available for lomerizine and quinoxalines

ArticleYear
Limiting oxidative stress following neurotrauma with a combination of ion channel inhibitors.
    Discovery medicine, 2017, Volume: 23, Issue:129

    Topics: Animals; Calcium; Central Nervous System; Humans; Imidazoles; Myelin Sheath; Nerve Degeneration; Oxidative Stress; Piperazines; Quinoxalines; Reactive Oxygen Species

2017

Other Studies

4 other study(ies) available for lomerizine and quinoxalines

ArticleYear
Chronological atrophy after transient middle cerebral artery occlusion in rats.
    Brain research, 1993, Aug-06, Volume: 618, Issue:2

    Topics: Animals; Atrophy; Brain; Calcium Channel Blockers; Cerebral Arteries; Excitatory Amino Acid Antagonists; Ischemic Attack, Transient; Male; Piperazines; Quinoxalines; Rats; Rats, Wistar; Time Factors

1993
Specific ion channels contribute to key elements of pathology during secondary degeneration following neurotrauma.
    BMC neuroscience, 2017, 08-14, Volume: 18, Issue:1

    Topics: Animals; Calcium Channel Blockers; Calcium Channels; Disease Models, Animal; Female; Imidazoles; Macrophages; Microglia; Nerve Degeneration; Nystagmus, Optokinetic; Optic Nerve Injuries; Oxidative Stress; Piperazines; Purinergic P2X Receptor Antagonists; Quinoxalines; Random Allocation; Ranvier's Nodes; Rats; Receptors, AMPA; Receptors, Purinergic P2X7

2017
Comparison of ion channel inhibitor combinations for limiting secondary degeneration following partial optic nerve transection.
    Experimental brain research, 2019, Volume: 237, Issue:1

    Topics: Animals; Calcium Channel Blockers; Calcium-Binding Proteins; Cell Adhesion Molecules, Neuronal; Disease Models, Animal; Drug Delivery Systems; Drug Therapy, Combination; Ectodysplasins; Female; Imidazoles; Ion Channels; Macrophages; Microfilament Proteins; Microglia; Nerve Degeneration; Nystagmus, Optokinetic; Oligodendrocyte Transcription Factor 2; Optic Nerve Injuries; Piperazines; Quinoxalines; Rats; Receptor, Platelet-Derived Growth Factor alpha; Rosaniline Dyes; Tubulin

2019
Comparing modes of delivery of a combination of ion channel inhibitors for limiting secondary degeneration following partial optic nerve transection.
    Scientific reports, 2019, 10-25, Volume: 9, Issue:1

    Topics: Animals; Calcium Channel Blockers; Calcium Channels; Drug Therapy, Combination; Female; Imidazoles; Myelin Sheath; Nerve Degeneration; Optic Nerve; Optic Nerve Injuries; Piperazines; Quinoxalines; Rats; Receptors, AMPA; Receptors, Purinergic P2X7; Rosaniline Dyes

2019